by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
ALPHARETTA, Ga., June 01, 2016 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the pricing of its initial...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
CALGARY, Alberta, June 01, 2016 (GLOBE NEWSWIRE) — Quattro Exploration and Production Ltd. (TSX-V:QXP) (“Quattro” or the “Company”) reports the release of its financial results for year-ended December 31st, 2015, reporting a CDN $0.08 per...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
NEWTOWN, Pa., June 01, 2016 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX) (“Onconova” or the “Company”), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced it...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
EL SEGUNDO, Calif., June 01, 2016 (GLOBE NEWSWIRE) — Griffin Capital Essential Asset REIT II, Inc. announced its operating results for the first quarter 2016. As of March 31, 2016, our portfolio consisted of 16 properties (20 buildings) encompassing...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
EL SEGUNDO, Calif., June 01, 2016 (GLOBE NEWSWIRE) — Griffin Capital Essential Asset REIT, Inc. announced its operating results for the first quarter 2016. As of March 31, 2016, our portfolio consisted of 75(1) assets encompassing approximately 18.8(1) million...
